1,457 Shares in Colgate-Palmolive (NYSE:CL) Purchased by Scarborough Advisors LLC

Scarborough Advisors LLC bought a new stake in Colgate-Palmolive (NYSE:CL) during the fourth quarter, HoldingsChannel reports. The institutional investor bought 1,457 shares of the company’s stock, valued at approximately $116,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth $731,843,000. Price T Rowe Associates Inc. MD lifted its holdings in Colgate-Palmolive by 16.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock worth $2,561,340,000 after purchasing an additional 4,625,472 shares in the last quarter. Magellan Asset Management Ltd boosted its stake in Colgate-Palmolive by 4,162.6% in the 4th quarter. Magellan Asset Management Ltd now owns 2,016,290 shares of the company’s stock worth $160,718,000 after purchasing an additional 1,968,988 shares during the period. FMR LLC increased its position in shares of Colgate-Palmolive by 27.3% during the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after buying an additional 1,199,660 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth about $62,728,000. 80.41% of the stock is owned by institutional investors.

Insider Activity

In other Colgate-Palmolive news, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $93.47, for a total transaction of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at $297,328.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider John W. Kooyman sold 3,497 shares of Colgate-Palmolive stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now owns 3,181 shares of the company’s stock, valued at approximately $297,328.07. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sally Massey sold 12,226 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. Argus increased their target price on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Evercore ISI lifted their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research note on Monday, April 8th. Morgan Stanley upped their target price on Colgate-Palmolive from $101.00 to $103.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 28th. Wells Fargo & Company lifted their price target on Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a research report on Monday, April 29th. Finally, Royal Bank of Canada upped their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday, April 29th. Three research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $92.94.

Colgate-Palmolive Stock Up 1.4 %

Shares of NYSE CL opened at $95.95 on Tuesday. The firm has a fifty day simple moving average of $91.86 and a two-hundred day simple moving average of $86.39. The firm has a market capitalization of $78.72 billion, a PE ratio of 30.36, a price-to-earnings-growth ratio of 3.48 and a beta of 0.39. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $96.08.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the business posted $0.73 earnings per share. Colgate-Palmolive’s quarterly revenue was up 6.2% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.08%. The ex-dividend date is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.